Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 6B, 2008, Pages 2586-2597

  Alexandru, N ^a   Jardin, I ^b   Popov, D ^a   Simionescu, M ^a   Garcia Estan J ^c   Salido, G M ^b   Rosado, J A ^b  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^b UNIVERSITY OF EXTREMADURA   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

Aggregation; Calcium signalling; Homocysteine; Platelets; ROS production; Thrombin

Indexed keywords

2-TERT-BUTYLHYDROQUINONE; CALCIUM; HOMOCYSTEINE; HYDROQUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; TERT BUTYLHYDROQUINONE; THROMBIN;

ARTICLE; BLOOD CLOTTING PARAMETERS; CASE CONTROL STUDY; CELL SHAPE; DRUG EFFECT; FEMALE; HEALTH; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE AGGREGATION;

BLOOD PLATELETS; CALCIUM; CASE-CONTROL STUDIES; CELL SHAPE; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH; HOMOCYSTEINE; HUMANS; HYDROQUINONES; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; REACTIVE OXYGEN SPECIES; THROMBIN;

EID: 58149466837     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00195.x     Document Type: Article

References (55)

1. Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost 2005 94 : 907 15.
2. Frantzen F, Faaren AL, Alfheim I, Nordhei AK. Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 1998 44 : 311 16.
3. Selhub J. Homocysteine metabolism. Ann Rev Nutr 1999 19 : 217 46.
4. Wierzbicki AS. Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res 2007 4 : 143 50.
5. Cattaneo M. Heperhomocysteinemia, atherosclerosis and thrombosis. Thromb. Haemost 1999 81 : 165 76.
6. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocys-teinemia in humans. Circulation 1999 100 : 1161 8.
7. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993 91 : 308 18.
8. Lentz SR. Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 2005 3 : 1646 54.
9. Coppola A, Davi G, De Stefano V, Mancini FP, Cerbone AM, Di Minno G. Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost 2000 26 : 243 54.
10. Leoncini G, Pascale R, Signorello MG. Effects of homocysteine on L-arginine transport and nitric oxide formation in human platelets. Eur J Clin Invest 2003 33 : 713 9.
11. Durand P, Lussier-Cacan S, Blache D. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 1997 11 : 1157 68.
12. Upchurch GR, Jr., Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF, Jr., Loscalzo J. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997 272 : 17012 7.
13. Leoncini G, Bruzzese D, Signorello MG. Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets. J Thromb Haemost 2006 4 : 209 16.
14. Leoncini G, Bruzzese D, Signorello MG. A role for PLCgamma2 in platelet activation by homocysteine. J Cell Biochem 2007 100 : 1255 65.
15. 2+ release from two different intracellular stores in human platelets. Biochem J 2007 401 : 167 74.
16. Redondo PC, Jardin I, Hernandez-Cruz JM, Pariente JA, Salido GM, Rosado JA. Hydrogen peroxide and peroxynitrite enhance Ca2+ mobilization and aggregation in platelets from type 2 diabetic patients. Biochem Biophys Res Commun 2005 333 : 794 802.
17. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 1998 47 : 1562 9.
18. Cooksey RC, Jouihan HA, Ajioka RS, Hazel MW, Jones DL, Kushner JP, McClain DA. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 2004 145 : 5305 12.
19. Cimminiello C, Milani M. Diabetes mellitus and peripheral vascular disease: is aspirin effective in preventing vascular events? Diabetologia 1996 39 : 1402 4.
20. 2+ entry and tyrosine kinase pp60src hyperactivity are modulated by hyperglycemia in platelets from patients with non insulin-dependent diabetes mellitus. Arch Biochem Biophys 2004 432 : 261 8.
21. 2+-ATPase function in platelets from patients with non-insulin-dependent diabetes melli-tus. Haematologica 2004 89 : 1142 4.
22. Signorello MG, Viviani GL, Armani U, Cerone R, Minniti G, Piana A, Leoncini G. Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus. Thromb Res 2007 120 : 607 13.
23. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985 260 : 3440 50.
24. 2+ entry in human platelets: evidence for involvement of small GTP-binding proteins and actin cytoskeleton. Biochem J 2000 347 : 183 92.
25. Redondo PC, Salido GM, Pariente JA, Rosado JA. Dual effect of hydrogen peroxide on store-mediated calcium entry in human platelets. Biochem Pharmacol 2004 67 : 1065 76.
26. Tintinger GR, Theron AJ, Potjo M, Anderson R. Reactive oxidants regulate membrane repolarization and store-operated uptake of calcium by formyl peptide-activated human neutrophils. Free Radic Biol Med 2007 42 : 1851 7.
27. 2+ ATPase system in human platelets. Br J Haematol 1997 97 : 192 203.
28. 2+ ATPase 3 protein. J Biol Chem 1994 269 : 1417 24.
29. Enyedi A, Paszty K, Kovacs T, Sarkadi B, Gardos G, Magnier C, Wuytack F, Enouf J. Simultaneous presence of two distinct endoplasmic-reticulum-type calcium-pump isoforms in human cells. Characterization by radio-immunoblotting and inhibition by 2,5-di-(t-butyl)-1,4-ben-zohydroquinone. Biochem J 1992 288 : 297 302.
30. 2+- and vacuolar H+-ATPases in human platelets. Biochem J 2005 390 : 243 52.
31. 2+ compartments show differential sensitivity to thrombin, ADP and vasopressin in human platelets. Cell Signal 2006 18 : 373 81.
32. Jardin I, Redondo PC, Salido GM, Rosado JA. Phosphatidylinositol 4,5-bis-phosphate enhances store-operated calcium entry through hTRPC6 channel in human platelets. Biochim Biophys Acta. 2007 doi :.
33. 2+ ATPase expression in diabetes: a novel signature of abnormal megakaryocy-topoiesis. J Thromb Haemost 2007 5 : 2127 35.
34. 2+-ATPase in hypertension. Hypertension 2000 35 : 103 7.
35. Avram S, Lupu A, Angelescu S, Olteanu N, Mut-Popescu D. Abnormalities of platelet aggregation in chronic myelopro-liferative disorders. J Cell Mol Med 2001 5 : 79 87.
36. Jardin I, Redondo PC, Salido GM, Pariente JA, Rosado JA. Endogenously generated reactive oxygen species reduce PMCA activity in platelets from patients with non-insulin-dependent diabetes melli-tus. Platelets 2006 17 : 283 8.
37. Leoncini G, Signorello MG, Piana A, Carrubba M, Armani U. Hyperactivity and increased hydrogen peroxide formation in platelets of NIDDM patients. Thromb Res 1997 86 : 153 60.
38. 2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production. Diabetologia 1999 42 : 167 76.
39. 2+ homeostasis and platelet hyper-aggregability in type 2 diabetes mellitus patients. Arch Biochem Biophys 2007 457 : 235 42.
40. 2+ release from two different intracellular stores in human platelets. Biochem J 2007 401 : 167 74.
41. Zhang HS, Xiao JH, Cao EH, Qin JF. Homocysteine inhibits store-mediated calcium entry in human endothelial cells: evidence for involvement of membrane potential and actin cytoskeleton. Mol Cell Biochem 2005 269 : 37 47.
42. Rosado JA, González A, Salido GM, Pariente JA. Effects of reactive oxygen species on actin filament polymerisation and amylase secretion in mouse pancreatic acinar cells. Cell Signal 2002 14 : 547 56.
43. Zhu D, Tan KS, Zhang X, Sun AY, Sun GY, Lee JC. Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astro-cytes. J Cell Sci 2005 118 : 3695 703.
44. Rosado JA, Salido GM, Jensen RT, Garcia LJ. Are tyrosine phosphorylation of p125(FAK) and paxillin or the small GTP binding protein, rho, needed for CCK-stimu-lated pancreatic amylase secretion? Biochim Biophys Acta 1998 1404 : 412 26.
45. 2+ entry: evidence for a secretion-like coupling model. Cell 1999 98 : 487 99.
46. Rosado JA, Sage SO. A role for the actin cytoskeleton in the initiation and maintenance of store-mediated calcium entry in human platelets. Trends Cardiovasc Med 2000 10 : 327 32.
47. Bouaziz A, Amor NB, Woodard GE, Zibidi H, Lopez JJ, Bartegi A, Salido GM, Rosado JA. Tyrosine phosphorylation / dephosphorylation balance is involved in thrombin-evoked microtubular reorganisation in human platelets. Thromb Haemost 2007 98 : 375 84.
48. 2+ entry: Dynamic interplay between endoplasmic reticulum, mitochondria and plasma membrane. J Physiol 2003 547 : 333 48.
49. Putney JW, Jr. Store-operated calcium channels: How do we measure them, and why do we care? Sci STKE 2004 243 : 1 3.
50. 2+ entry: vesicle fusion or reversible trafficking and de novo conformational coupling? J Cell Physiol 2005 205 : 262 9.
51. Ho PI, Collins SC, Dhitavat S, Ortiz D, Ashline D, Rogers E, Shea TB. Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress. J Neurochem 2001 78 : 249 53.
52. 2+ mobilisation in human platelets through sulphydryl oxidation dependent and independent mechanisms. Biochem Pharmacol 2004 67 : 491 502.
53. 2+ flux in pulmonary vascular endothelial cells. Am J Physiol 1991 260 : H549 56.
54. Koubaa N, Nakbi A, Smaoui M, Abid N, Chaaba R, Abid M, Hammami M. Hyperhomocysteinemia and elevated ox-LDL in Tunisian type 2 diabetic patients: Role of genetic and dietary factors. Clin Biochem 2007 40 : 1007 14.
55. Rasouli ML, Nasir K, Blumenthal RS, Park R, Aziz DC, Budo-ff MJ. Plasma homocysteine predicts progression of atherosclerosis. Atherosclerosis 2005 181 : 159 65.